Tellgen Corporation (300642.SZ)

CNY 15.31

(-0.07%)

Market Cap (In CNY)

2.49 Billion

Revenue (In CNY)

542.8 Million

Net Income (In CNY)

89.4 Million

Avg. Volume

4.3 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.94-19.2
PE
-
EPS
-
Beta Value
0.415
ISIN
CNE100002P42
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Jian Er Yao
Employee Count
-
Website
https://www.tellgen.com
Ipo Date
2017-04-21
Details
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.